Phoreus Biotechnology, Inc. — Form D

Phoreus Biotechnology, Inc. of OLATHE, KS, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-13. $421K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Bill AshleyDirectorOverland Park, KS
Scott NagleyDirectorDenver, CO
David SchaeferDirectorClearwater Beach, FL
Steve SchramDirectorGoodyear, AZ
Douglas ShaneDirectorLouisburg, KS
David SchaeferExecutive OfficerClearwater Beach, FL
Bill AshleyPromoterOverland Park, KS
Rajeet PannuPromoterNew York, NY
David SchaeferPromoterClearwater Beach, FL
Steve SchramPromoterGoodyear, AZ
Douglas ShanePromoterLouisburg, KS
Matthew TomichPromoterSeattle, WA
Christopher BrandtDirectorBaltimore, MD
Michael CoeDirectorPerry, KS
Michael CoeExecutive OfficerPerry, KS
Lynn RundleDirectorAbingdon, VA
Bradley HollidayDirectorKansas City, MO
Nathan SinghDirectorSaint Louis, MO
Matthew TomichDirectorSeattle, WA
Matthew TomichRelated PersonSeattle, WA
Randall ToshDirectorOlathe, KS
Randall ToshExecutive OfficerOlathe, KS
Rajeet PannuDirectorNew York, NY
Rajeet PannuRelated PersonNew York, NY
Xiomara Sinisterra-HunterDirectorPort Saint Lucie, FL

Other filings by this issuer (6)

FiledFormOfferingSold
2026-03-13D/A$4.4M
2022-05-11D/A$3.0M$1.9M
2020-05-26D$2.0M
2019-12-30D/A$1.1M$550K
2019-07-19D/A$1.1M$300K
2018-08-02D$1.0M$50K

More